BlackRock Updates Boston Scientific Stake in SC 13G/A Filing
Ticker: BSX · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 885725
| Field | Detail |
|---|---|
| Company | Boston Scientific CORP (BSX) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock just updated its Boston Scientific holdings, signaling continued institutional interest.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Boston Scientific Corp. common stock as of December 31, 2023. This filing, Amendment No. 12, updates their previous disclosures regarding their investment in the medical device company. For investors, this matters because BlackRock is a major institutional investor, and changes in their reported holdings can signal shifts in their investment strategy or outlook on Boston Scientific's future performance.
Why It Matters
This filing shows BlackRock's continued significant institutional ownership in Boston Scientific, which can influence market perception and stock stability. Large institutional holdings often suggest confidence in a company's long-term prospects.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should note BlackRock's continued presence as a major shareholder, which can be a sign of stability, but should also monitor future filings for any significant changes in their reported ownership percentage.
Key Numbers
- 101137107 — CUSIP Number (identifies Boston Scientific Corp. Common Stock)
- 0001364742 — BlackRock Inc. CIK (Central Index Key for the reporting entity)
- 0000885725 — Boston Scientific Corp. CIK (Central Index Key for the subject company)
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- BOSTON SCIENTIFIC CORP (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 25, 2024 (date) — the filing date of the SC 13G/A
- Amendment No: 12 (number) — the specific amendment number of the filing
Forward-Looking Statements
- BlackRock will maintain a significant stake in Boston Scientific throughout 2024. (BlackRock Inc.) — high confidence, target: December 31, 2024
FAQ
What type of filing is this and what does it generally indicate?
This is an SC 13G/A filing, which is an amendment to a Schedule 13G. It indicates that a passive institutional investor, in this case BlackRock Inc., is updating its ownership stake in a public company, Boston Scientific Corp., as of a specific date, December 31, 2023.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., a large institutional asset manager with a Central Index Key (CIK) of 0001364742, located at 50 Hudson Yards, New York, NY.
Which company's securities are being reported on?
The securities being reported on belong to BOSTON SCIENTIFIC CORP, identified by CIK 0000885725 and CUSIP number 101137107, with its business address at 300 Boston Scientific Way, Marlborough, MA.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, meaning the reported ownership reflects BlackRock's holdings as of the end of last year.
What is the significance of 'Amendment No: 12'?
The 'Amendment No: 12' indicates that this is the twelfth update or revision BlackRock Inc. has made to its Schedule 13G filing regarding its ownership in Boston Scientific Corp., suggesting a history of significant and ongoing investment in the company.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding BOSTON SCIENTIFIC CORP (BSX).